INDIANAPOLIS — Here are Thursday's latest updates on the coronavirus pandemic, including the latest news on COVID-19 vaccinations and testing in Indiana.
Registrations for the vaccine are now open for Hoosiers 5 and older through the Indiana State Department of Health. This story will be updated over the course of the day with more news on the COVID-19 pandemic.
Latest US, world numbers
There have been more than 85.21 million confirmed cases of COVID-19 in the United States as of 4:30 a.m. ET Thursday, according to Johns Hopkins University. There have been more than 1,010,520 deaths recorded in the U.S.
Worldwide, there have been more than 533.67 million confirmed coronavirus cases with more than 6.30 million deaths and more than 11.52 billion vaccine doses administered.
For most people, the coronavirus causes mild or moderate symptoms. For some, especially older adults and people with existing health problems, it can cause more severe illness like pneumonia, or death.
CDC map shows 13 Indiana counties at 'medium' risk
On Thursday, June 9, 2022, 13 Indiana counties (LaPorte, St. Joseph, Starke, Marshall, Pulaski, Fulton, Benton, White, Tippecanoe, Carroll, Clinton, Lawrence, Orange) were listed on the CDC data map as having "medium" community risk of spreading COVID-19. Surrounding Indiana, the Louisville (medium) and Chicago (high) metro areas are also deemed at risk by the CDC.
Moderna says updated COVID shot boosts omicron protection
Moderna's experimental COVID-19 vaccine that combines its original shot with protection against the omicron variant appears to work, the company announced Wednesday.
COVID-19 vaccine makers are studying updated boosters that might be offered in the fall to better protect people against future coronavirus surges.
Moderna's preliminary study results show people given the combination shot experienced an eight-fold increase in virus-fighting antibodies capable of targeting the omicron mutant, the company announced.
Today’s COVID-19 vaccines all are based on the original version of the coronavirus. They’re still providing strong protection against severe disease, hospitalization and death even after the appearance of the super-contagious omicron variant -- especially if people have had a booster dose.
But the virus continues to mutate rapidly in ways that let it evade some of the vaccines’ protections and cause milder infections.
So U.S. regulators, and the World Health Organization, are considering whether to order a change in the vaccine recipe for a new round of booster shots in the fall -- when cold weather and kids returning to school are expected to drive yet another surge.
FDA advisers back Novavax COVID-19 shots as new US option
American adults who have yet to get vaccinated against COVID-19 may soon have another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot.
Next, the FDA must decide whether to authorize the vaccine made by latecomer Novavax, a protein vaccine that's made with a more conventional technology than today's U.S. options.
Novavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company.
FDA's vaccine chief Dr. Peter Marks said another choice in the U.S. may entice at least some vaccine holdouts — whatever their reason — to consider rolling up their sleeves.
If the FDA authorizes Novavax as the nation's fourth vaccine, it’s not clear how widely it would be used — at least right away.
About 27 million U.S. adults remain unvaccinated. Eventually, Novavax hopes to also become a choice for the millions more who have not had a booster dose of the vaccines already available.
The shots are used elsewhere as a booster, regardless of which vaccine people got originally.
CDC data shows 82 million vaccine doses wasted
Pharmacies, states, U.S. territories and federal agencies discarded 82.1 million COVID-19 vaccine doses from December 2020 through mid-May 2022 — just over 11% of the doses the federal government distributed, according to data the Centers for Disease Control and Prevention shared with NBC News.
That’s an increase from the 65 million doses the CDC told the Associated Press had been wasted as of late February.
Two retail pharmacy chains, CVS and Walmart, were responsible for over a quarter of the doses thrown away in the United States in that time period, in part due to the sheer volume of vaccine they handled.
Five other pharmacies or dialysis centers — Health Mart, DaVita, Rite Aid, Publix and Costco — wasted fewer overall doses, but a higher share: more than a quarter of the vaccine doses they received, well above the national average. Two states also discarded more than a quarter of their doses: Oklahoma, which tossed 28% of the nearly 4 million doses it received, and Alaska, which threw away almost 27% of its 1 million doses, according to the CDC data.
The overall amount of waste is in line with World Health Organization estimates for large vaccination campaigns. But public health experts said the waste is still alarming at a time when less than half of fully vaccinated Americans have a booster shot — which is critical to fight newer, more contagious virus strains — and when many poorer countries continue to struggle with vaccine supply.
US making COVID-19 antiviral drug more available at test sites
The White House has announced more steps to make the antiviral treatment Paxlovid more accessible across the U.S. as it projects COVID-19 infections will continue to spread over the summer travel season.
The nation’s first federally backed test-to-treat site is opened Thursday in Rhode Island. The site will provide patients with immediate access to the drug once they test positive.
More federally supported sites are set to open in the coming weeks in Massachusetts and New York City, both hit by a marked rise in infections.
Next week, the U.S. will send authorized federal prescribers to several Minnesota-run testing sites, turning them into test-to-treat locations.
White House offering additional 8 free COVID-19 tests to public
The government website for people to request free COVID-19 at-home tests from the U.S. government is now accepting a third round of orders.
The White House recently announced that U.S. households can request an additional eight free at-home tests to be shipped by the U.S. Postal Service.
President Joe Biden committed in January to making 1 billion tests available to the public free of charge, including 500 million available through covidtests.gov. But just 350 million of the amount available for ordering online have been shipped to date to addresses across the continental U.S., its territories and overseas military bases, the White House said.
People who have difficulty getting online or need help placing an order can call 1-800-232-0233 for assistance.
The third round brings to 16 the total number of free tests available to each U.S. household since the program started earlier this year. Households were eligible to receive four tests during each of two earlier rounds of ordering through the website.
2nd COVID-19 booster shot available to Hoosiers 50 and up
The Indiana Department of Health announced that Hoosiers age 50 and older, as well as those 12 and older with weakened immune systems, are now eligible to receive a second mRNA COVID-19 booster shot at least four months after their first booster dose.
The announcement comes one day after the Food and Drug Administration authorized an extra dose of the Pfizer or Moderna vaccine for that age group and and certain younger people with severely weakened immune systems.
The Centers for Disease Control and Prevention later recommended the extra shot as an option but stopped short of urging that those eligible rush out and get it right away.
The IDOH is advising vaccine providers that they can begin administering second boosters of the Moderna and Pfizer vaccines to people who qualify.
The CDC also says that adults who received a primary vaccine and booster dose of the Johnson & Johnson vaccine at least four months ago may now receive a second booster dose of either mRNA vaccine.
You can find a vaccine location at ourshot.in.gov or by calling Indiana 211 (866-211-9966). Appointments are recommended, but many sites do accept walk-ins.